Annual report pursuant to Section 13 and 15(d)

QUARTERLY FINANCIAL INFORMATION (UNAUDITED)

v3.20.4
QUARTERLY FINANCIAL INFORMATION (UNAUDITED)
12 Months Ended
Dec. 31, 2020
Quarterly Financial Information Disclosure [Abstract]  
QUARTERLY FINANCIAL INFORMATION (UNAUDITED)

24.

QUARTERLY FINANCIAL INFORMATION (UNAUDITED)

 

 

 

2019

 

 

 

First

Quarter

 

 

Second

Quarter

 

 

Third

Quarter

 

 

Fourth

Quarter

 

 

Full

Year

 

Revenues

 

$

714,723

 

 

$

957,756

 

 

$

821,817

 

 

$

788,803

 

 

$

3,283,099

 

Operating income

 

$

57,368

 

 

$

156,052

 

 

$

58,531

 

 

$

66,436

 

 

$

338,387

 

Net income

 

$

33,193

 

 

$

101,861

 

 

$

31,955

 

 

$

26,839

 

 

$

193,848

 

Net income attributable to Cinemark Holdings, Inc.

 

$

32,728

 

 

$

100,971

 

 

$

31,353

 

 

$

26,334

 

 

$

191,386

 

Net income per share attributable to Cinemark Holdings, Inc.’s common stockholders:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Basic

 

$

0.28

 

 

$

0.86

 

 

$

0.27

 

 

$

0.22

 

 

$

1.63

 

Diluted

 

$

0.28

 

 

$

0.86

 

 

$

0.27

 

 

$

0.22

 

 

$

1.63

 

 

 

 

2020(1)

 

 

 

First

Quarter

 

 

Second

Quarter

 

 

Third

Quarter

 

 

Fourth

Quarter

 

 

Full

Year

 

Revenues

 

$

543,616

 

 

$

8,974

 

 

$

35,478

 

 

$

98,242

 

 

$

686,310

 

Operating income (loss)

 

$

(42,919

)

 

$

(214,275

)

 

$

(210,784

)

 

$

(286,996

)

 

$

(754,974

)

Net income (loss)

 

$

(59,422

)

 

$

(170,816

)

 

$

(148,036

)

 

$

(239,674

)

 

$

(617,948

)

Net income (loss) attributable to Cinemark Holdings, Inc.

 

$

(59,591

)

 

$

(170,389

)

 

$

(147,592

)

 

$

(239,256

)

 

$

(616,828

)

Net income (loss) per share attributable to Cinemark Holdings, Inc.’s common stockholders:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Basic

 

$

(0.51

)

 

$

(1.45

)

 

$

(1.25

)

 

$

(2.03

)

 

$

(5.25

)

Diluted

 

$

(0.51

)

 

$

(1.45

)

 

$

(1.25

)

 

$

(2.03

)

 

$

(5.25

)

 

(1)

 Quarterly results during the year ended December 31, 2020 were impacted by the COVID-19 pandemic (see Note 3) as well as impairment recorded (see Notes 1 and 11).